Professional Summary
Professional Overview
Kelly Morton is an accomplished Group Product Director in the Oncology Market Access Marketing, CAR-T division at Johnson & Johnson. With extensive expertise in the pharmaceutical industry, she specializes in driving strategic initiatives and delivering impactful solutions to address the evolving needs of the oncology market.
Experience Summary
Current Role
As the Group Product Director, Oncology Market Access Marketing, CAR-T at Johnson & Johnson, Kelly is responsible for leading the development and implementation of market access strategies for the company's CAR-T therapies. She works closely with cross-functional teams to optimize product positioning, pricing, and reimbursement, ensuring the successful commercialization of these innovative oncology treatments.
Career Progression
Prior to her current role, Kelly served as the Product Director, Local Market Solutions, CAR-T at Johnson & Johnson, where she leveraged her expertise to design and execute effective market access programs tailored to specific regional and local market dynamics. Before that, she held the position of District Manager at Johnson & Johnson, demonstrating her versatility and adaptability within the organization.
Earlier in her career, Kelly gained valuable experience as an Adverse Event Specialist at Wyeth, where she contributed to the company's pharmacovigilance efforts and gained a deep understanding of the regulatory landscape in the pharmaceutical industry.
Academic Background
Kelly holds a relevant educational background, although specific details are not provided in the information given.
Areas of Expertise
Kelly's core areas of expertise include:
- Oncology market access strategy
- CAR-T therapy commercialization
- Product positioning and pricing
- Reimbursement optimization
- Cross-functional collaboration
- Pharmaceutical industry regulations and compliance
Professional Impact
Throughout her career, Kelly has demonstrated a track record of driving meaningful impact within the pharmaceutical industry. She has consistently delivered innovative market access solutions that have contributed to the successful commercialization of oncology therapies, ultimately improving patient outcomes.
Conclusion
With her deep industry knowledge, strategic mindset, and proven leadership abilities, Kelly Morton is poised to continue making significant contributions to the oncology market access landscape at Johnson & Johnson. Her unwavering commitment to delivering transformative solutions positions her as a valuable asset to the organization and the patients it serves.
